Family Medicine Doctors in Lynwood, CA Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Dr. Yohannes Assefa, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3628 E Imperial Hwy Ste 202, Lynwood, CA 90262 Phone: 310-900-5010

Dr. Basil Felahy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11050 Atlantic Ave, Lynwood, CA 90262 Phone: 310-635-3800    Fax: 310-635-0364

Dr. Usha Chopra, M. D. Family Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 3820 Martin Luther King Jr Blvd, Lynwood, CA 90262 Phone: 310-632-0415

Dr. Constant K.s. Chan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10007 State St, Lynwood, CA 90262 Phone: 323-566-3157    Fax: 323-566-2676

Harding G Young, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3617 Martin Luther King Jr Blvd, Suite 1, Lynwood, CA 90262 Phone: 310-631-2660

Dr. Eduardo Jose Gonzalez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3625 Martin Luther King Jr Blvd, Suite 7, Lynwood, CA 90262 Phone: 310-763-1336    Fax: 310-763-1350

News Archive

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Glutamate is the primary excitatory neurotransmitter in the brain, which has been implicated in drug addiction. Metabotropic glutamate receptors (mGluRs) represent a family of G-protein coupled receptors that modulate glutamate transmission. Glutamate is an important neurotransmitter involved in learning and memory. Today, these receptors are considered to be promising targets for drug discovery, with therapeutic potential to treat various neurological and psychiatric disorders, including drug addiction.

FDA grants Fast Track designation for ARCA biopharma's Gencaro

ARCA biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.

New 3D printed insoles can improve foot health of people with diabetes

Scientists from Staffordshire University claim that new 3D printed insoles can significantly improve the foot health of people suffering with diabetes.

Six Beijing Xiang Yun Kang Drugstores to be acquired by China Nepstar Chain Drugstore

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China based on the number of directly operated stores, today announced that it has entered into a definitive agreement with Beijing Xiang Yun Kang Drugstore, to acquire all of its six drugstores in Beijing. This acquisition will be China Nepstar's second acquisition in Beijing.

Read more Medical News

› Verified 3 days ago